Evidence map›Paper›PMID 36694695›Full record

ArticleExperimental and computational multiphase flow2023

Prediction of transport, deposition, and resultant immune response of nasal spray vaccine droplets using a CFPD-HCD model in a 6-year-old upper airway geometry to potentially prevent COVID-19.

Hamideh Hayati, Yu Feng, Xiaole Chen, Emily Kolewe, Catherine Fromen

Open access · bronzeAbstract read
In one paragraph

Article in Experimental and computational multiphase flow, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Message from the Guest Editor of the SCONA 2022 Meeting Special Issue.Experimental and computational multiphase flow · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hamideh HayatiSchool of Chemical Engineering, Oklahoma State University, Stillwater, OK 74078 USA.
Yu FengSchool of Chemical Engineering, Oklahoma State University, Stillwater, OK 74078 USA.
Xiaole ChenSchool of Energy and Mechanical Engineering, Nanjing Normal University, Nanjing, 210042 China.
Emily KoleweDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716 USA.
Catherine FromenDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716 USA.
Oklahoma State University · USUniversity of Delaware · USNanjing Normal University · CN

Funding

ZFC3H1 Regulation of Host Defense and Influenza A Virus PathogenesisP20GM103648 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI CHENG, YONG · 2013 to 2022
$22.3M
NIGMS NIH HHS P20 GM103648
6 · The paper itself

Abstract

This study focuses on the transport, deposition, and triggered immune response of intranasal vaccine droplets to the angiotensin-converting-enzyme-2-rich region, i.e., the olfactory region (OR), in the nasal cavity of a 6-year-old female to possibly prevent corona virus disease 19 (COVID-19). To investigate how administration strategy can influence nasal vaccine efficiency, a validated multi-scale model, i.e., computational fluid-particle dynamics (CFPD) and host-cell dynamics (HCD) model, was employed. Droplet deposition fraction, size change, residence time, and the area percentage of OR covered by the vaccine droplets, and triggered immune system response were predicted with different spray cone angles, initial droplet velocities, and compositions. Numerical results indicate that droplet initial velocity and composition have negligible influences on the vaccine delivery efficiency to OR. In contrast, the spray cone angle can significantly impact the vaccine delivery efficiency. The triggered immunity was not significantly influenced by the administration investigated in this study due to the low percentage of OR area covered by the droplets. To enhance the effectiveness of the intranasal vaccine to prevent COVID-19 infection, it is necessary to optimize the vaccine formulation and administration strategy so that the vaccine droplets can cover more epithelial cells in OR to minimize the number of available receptors for SARS-CoV-2.

Indexed as

6-year-old femaleangiotensin-converting enzyme 2 (ACE-2)computational fluid-particle dynamics (CFPD)COVID-19host-cell dynamics (HCD)SARS-CoV-2 intranasal vaccine

Identifiers

PMID36694695
PMCPMC9851113
OpenAlexW4317438799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.